Renaissance Technologies
GUTS icon

Renaissance Technologies’s Fractyl Health GUTS Stock Holding History

Renaissance Technologies’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1K Sell
35,200
-1,827,851
-98% -$1.69M ﹤0.01% 3181
2025
Q4 		$4.1M Buy
1,863,051
+1,086,351
+140% +$1.75M 0.01% 1417
2025
Q3 		$1.23M Buy
+776,700
New +$1.01M ﹤0.01% 2376
2024
Q4 		– Sell
-62,695
Closed -$159K – 3964
2024
Q3 		$159K Buy
62,695
+48,495
+342% +$158K ﹤0.01% 3172
2024
Q2 		$60.6K Buy
+14,200
New +$91.4K ﹤0.01% 3262

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies's GUTS Position: Q1 2026 in Review

Renaissance Technologies reduced its Fractyl Health (GUTS) stake by 98% in Q1 2026, selling an estimated $1.69M and leaving 35,200 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3181.

Renaissance Technologies first reported a position in GUTS in Q2 2024 and has held it in 5 quarters since. The position peaked at $4.1M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Renaissance Technologies held 35,200 shares of Fractyl Health worth $16.1K as of Q1 2026.
  • Renaissance Technologies sold 1,827,851 Fractyl Health shares in Q1 2026, an estimated $1.69M.
  • Fractyl Health made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3181 holding.
  • Renaissance Technologies first reported a position in Fractyl Health in Q2 2024 and has held it in 5 quarters since.
  • Renaissance Technologies's Fractyl Health position peaked at $4.1M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.